Beat Multiple Sclerosis » Laquinimod http://beatmultiplesclerosis.com A Good News Portal For People With MS Fri, 11 Jun 2010 13:28:06 +0000 http://wordpress.org/?v=2.9.2 en hourly 1 Oral Medication My Reduce Lesions http://beatmultiplesclerosis.com/2009/03/oral-medication-my-reduce-lesions/ http://beatmultiplesclerosis.com/2009/03/oral-medication-my-reduce-lesions/#comments Sat, 28 Mar 2009 12:53:33 +0000 admin http://beatmultiplesclerosis.com/?p=23 There is hope that this new medicine will replace daily injections. Laquinimod has been in the pipeline for a while and study results have been out for a few months.

“These latest data show the rapid onset and sustainability of laquinimod efficacy in MS patients,” said Giancarlo Comi, M.D., University Vita-Salute San Raffaele, Scientific Institute San Raffaele, Milan, Italy, principal investigator of the study. “Just as exciting is the fact that, with increased number of patients exposed to laquinimod, we found no new risks or safety issues. This reinforces earlier results demonstrating the laquinimod safety profile. The MS community looks forward to future data as we continue enrolling patients in the laquinimod Phase III clinical program.”laquinimod

These new data from the extension study build upon the initial 36-week, Phase IIb study results published in The Lancet*, which demonstrated that once-daily, oral 0.6mg laquinimod significantly reduced MRI disease activity by a median of 60 percent, compared to placebo, and was well tolerated.

From MedicalNewsToday

Treatment with laquinimod reduces development of active MRI lesions in relapsing MS

Oral laquinimod for multiple sclerosis granted fast track status by FDA

]]> http://beatmultiplesclerosis.com/2009/03/oral-medication-my-reduce-lesions/feed/ 0